Matthew Charles McMurdo

Matthew Charles McMurdo discloses dealings in 3 companies, chiefly Titan Pharmaceuticals Inc, FiEE, Inc. and CapForce Inc. Between 26 July 2023 and 26 September 2024, the trades on record add up to 6 filings.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 1 October 2024 came the latest disclosure, a share grant in FiEE, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.